Watch Ticker

Mirati Therapeutics, Inc. Common Stock

Go to Mirati Therapeutics, Inc. Common Stock Website

$58.70

(%)

Live

Previous Close

$58.7

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$

Day Vol.

Previous Day Vol.

Currency

Primary Exchange

Nasdaq

...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Zacks Equity Research - Mirati (MRTX) Gets EU Nod for Krazati in KRAS-Mutated NSCLC

Mirati's (MRTX) Krazati gets the European Commission's conditional marketing approval for treating adult patients with KRASG12C-mutated advanced non-small cell lung cancer.

Related tickers: BMY, PBYI, MRTX, FRLN.

Read Full Article

Zacks Equity Research - Bristol Myers (BMY) NSCLC Drug Application Gets EMA Validation

Bristol Myers' (BMY) repotrectinib is under review in the European Union for the treatment of locally advanced or metastatic ROS1-Positive NSCLC and NTRK-positive solid tumors.

Related tickers: BMY, MRK, MRTX, TRDA.

Read Full Article

Trending Tickers

Please sign in to view